More Than Half of U.S. Adults Could Benefit From GLP-1 Medications, Researchers Find
In a new analysis of national data, researchers at the Richard A. and Susan F. Smith Center for Outcomes Research at Beth Israel Deaconess Medical Center (BIDMC) estimated that 137 million U.S. adults, more than half of all adults, are eligible for...
20-Nov-2024 3:45 PM EST
Add to Favorites